Abstract:The prevalence of peripheral artery disease (PAD) in the general population is about 12% to 14% and it increases with age. PAD increased from 164 million people in 2000 to 202 million people in 2010. More than two‐thirds of people with PAD are based in low‐ or middle‐income countries. Critical limb ischaemia (CLI) occurs in 1% to 2% of people with intermittent claudication over five years. One third of people with CLI have isolated below the knee (BTK) lesions. CLI and isolated BTK lesions are associated with a higher incidence of limb loss when compared with people with multilevel arterial disease. Endovascular procedures such as angioplasty (with or without stenting) are widely used to treat isolated BTK lesions, aiming to improve blood flow and limb salvage. The technical success of any angioplasty procedure depends on the ability to cross the target lesion. Failed attempts are underestimated in the literature and failures in the real world appear to be higher than reported. People with isolated BTK lesions undergoing angioplasty by conventional femoral access present a high failure rate to cross these lesions. Retrograde distal access may provide some advantages that can lead to successful crossing of the target lesion. To evaluate the benefits and harms of retrograde distal access versus conventional femoral access for people undergoing below the knee angioplasty. The Cochrane Vascular Information Specialist searched the Cochrane Vascular Specialised Register, CENTRAL, MEDLINE, Embase and CINAHL databases, and World Health Organization International Clinical Trials Registry Platform and ClinicalTrials.gov trials registers to 26 September 2022. We planned to include randomised or quasi‐randomised controlled trials comparing people undergoing retrograde distal access versus people undergoing conventional femoral access (ipsilateral antegrade or contralateral retrograde) for BTK angioplasty. Two review authors independently assessed identified studies for potential inclusion in the review. We used standard methodological procedures in accordance with the Cochrane Handbook for Systematic Review of Interventions . Our primary outcomes were technical success of angioplasty procedure and major procedural complications. Our secondary outcomes were mortality rate, amputation‐free survival, primary patency, minor procedural complications and wound healing. We planned to use GRADE to assess the certainty of the evidence for each outcome. We identified no randomised or quasi‐randomised controlled trials that met the inclusion criteria. We identified no randomised or quasi‐randomised controlled trials that compared retrograde distal access versus femoral access for BTK angioplasty. High‐quality studies that compare retrograde distal access versus conventional femoral access for BTK angioplasty are needed. Key messages – The choice of vascular access can influence the outcome of below the knee angioplasty. – We identified no trials that compared retrograde distal access with femoral access for below the knee angioplasty for inclusion; there is a need for high‐quality trials on this topic. What is peripheral artery disease? Peripheral artery disease is a stenosis (narrowing) or occlusion (blocking) of the limb arteries usually caused by the build‐up of fatty deposits in the arteries (known as lesions) restricting blood flow to the muscles. About 12% to 14% of people in the general population have peripheral artery disease and it increases with age. Worldwide, peripheral artery disease increased from 164 million people in 2000 to 202 million people in 2010. More than two‐thirds of people with peripheral artery disease are based in low‐ or middle‐income countries. Peripheral artery disease can lead to critical limb ischaemia, which is caused by severe lack of circulation in the limbs, leading to pain or wounds. One third of people with critical limb ischaemia have lesions below the knee, which are associated with a higher risk of lower‐leg amputation. How is peripheral artery disease treated? The treatment for people with critical limb ischaemia is to unclog the blood vessel using angioplasty, which involves using a balloon to stretch open a narrowed or blocked artery and possibly inserting a tube (stent) to keep the artery open. The technical success of any angioplasty procedure depends on the ability to get through (cross) the lesions. Conventionally, this angioplasty is performed using a catheter (tube) inserted through the femoral artery (major artery running down the thigh), but there is a high rate of failure when trying to push through the lesion in this way. Coming from the other direction through the retrograde distal puncture (catheter insertion through the arteries close to the ankle) may make it easier to cross the lesions. What did we want to find out? We wanted to evaluate the benefits and harms of retro -Abstract Truncated-

Retrograde endovascular angioplasty and conventional anterograde endovascular angioplasty for the treatment of below-the-knee arterial occlusion diseases：a comparative study

Retrograde transplantar arch angioplasty of below-the-knee arterial occlusions: outcomes compared to anterograde recanalization.

Retrograde Transdorsal-To-Plantar or Transplantar-To-Dorsal Intraluminal Re-Entry Following Unsuccessful Subintimal Angioplasty for Below-The-Ankle Arterial Occlusion

Retrospective Case Control Matched Comparison of the Antegrade Versus Retrograde Strategy After Antegrade Recanalisation Failure in Complex de novo Femoropopliteal Occlusive Lesions

Retrograde Tibial Approach for Endovascular Recanalization of Popliteal and Tibioperoneal Artery Occlusion

Integrated Application of Antegrade and Retrograde Recanalization for Femoral-Popliteal Artery Chronic Total Occlusions: Outcomes Compared with Antegrade Recanalization.

Anterograde puncture endovascular treatment for below-knee arteriosclerotic obliteration of lower extremities: a clinical evaluation

Efficacy of retrograde revascularization in diabetic patients with chronic limb-threatening ischemia after a failed antegrade approach

Comparison of the clinical effects of endovascular therapy and bypass surgery for Trans-Atlantic Inter-Society ConsensusⅡC/D femoropopliteal artery disease

Retrograde distal access versus femoral access for below the knee angioplasty

The Efficacy Analysis of Endovascular Intervention Therapy for Transatlantic Inter Society Consensus Type C and Type D Femoropopliteal Arteriosclerosis Lesion

Analysis of results of the below-the-knee endovascular therapy for critical limb ischemia

Endovascular intervention for infrapopliteal arterial ischemia

[Comparison of the Clinical Efficacy of Endovascular Reconstruction Versus Bypass Surgery for Transatlantic Inter-Society Consensus II C/D Femoropopliteal Artery Lesion Resulted from Arteriosclerosis Obliterans].

Endovascular noninvasive technology for the treatment of atherosclerotic occlusion of infrapopliteal artery

Outcomes of Endovascular Recanalization Versus Autogenous Venous Bypass for Thromboangiitis Obliterans Patients with Critical Limb Ischemia Due to Tibioperoneal Arterial Occlusion

Endovascular Interventions for Transatlantic Intersociety Consensus Ii C and D Femoropopliteal Lesions

Augmented Reality Navigation to Assist Retrograde Peroneal Access for the Endovascular Treatment of Critical Limb Ischemia.

Analysis to Angioplasty and Bypass Surgery for Occlusive Lnfrapopliteal Artery Disease

Endovascular Treatment for Chronic Lower Extremity Ischaemia with Sub-Acute Deterioration

Retrograde Approach for the Recanalization of Coronary Chronic Total Occlusion: Preliminary Experience of a Single Center.